Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000905148-16-001673
Filing Date
2016-06-13
Accepted
2016-06-13 16:02:19
Documents
2
Period of Report
2016-06-10

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 1405
2 efc16-409_ex241.htm EX-24.1 11109
  Complete submission text file 0000905148-16-001673.txt   13901
Mailing Address C/O GERON CORPORATION 230 CONSTITUTION DRIVE MENLO PARK CA 94025
Business Address
SCARLETT JOHN A (Reporting) CIK: 0001270928 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37587 | Film No.: 161710793

Mailing Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Issuer) CIK: 0001501989 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations